The Clinical Value of Serum KL-6 Changes on Evaluating Disease Development in Different Diffuse Parenchymal Lung Disease
Condition(s):Diffuse Parenchymal Lung DiseaseLast Updated:April 13, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Diffuse Parenchymal Lung DiseaseLast Updated:April 13, 2017Unknown status
Condition(s):Interstitial Lung Disease; Pulmonary Hypertension; BiomarkersLast Updated:September 18, 2012Completed
Condition(s):Respiratory Distress Syndrome; Chronic Lung Disease of PrematurityLast Updated:August 8, 2012Unknown status
Condition(s):Covid19; COVID-19 Pneumonia; Interstitial Lung DiseaseLast Updated:October 10, 2023Completed
Condition(s):Scleroderma; Interstitial Lung DiseaseLast Updated:February 10, 2017Completed
Condition(s):Interstitial Lung DiseaseLast Updated:October 26, 2016Unknown status
Condition(s):Interstitial Lung DiseaseLast Updated:November 2, 2018Completed
Condition(s):Interstitial Lung DiseaseLast Updated:April 25, 2022Completed
Condition(s):Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)Last Updated:March 27, 2024Recruiting
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:September 2, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.